Verschueren, P
De Cock, D
Corluy, L
Joos, R
Langenaken, C
Taelman, V
Raeman, F
Ravelingien, I
Vandevyvere, K
Lenaerts, J
Geens, E
Geusens, P
Vanhoof, J
Durnez, A
Remans, J
Vander Cruyssen, B
Van Essche, E
Sileghem, A
De Brabanter, G
Joly, J
Meyfroidt, S
Van der Elst, K
Westhovens, R
Maeyaert, B
De Brabanter, G
Devinck, M
Langenaken, C
Lenaerts, J
Corluy, L
Remans, J
Vander Cruyssen, B
Ravelingien, I
Van Essche, E
Vandevyvere, K
Durnez, A
Verbruggen, A
Geens, E
Raeman, F
Joos, R
de Vlam, K
Taelman, V
Vanhoof, J
Coppens, M
Geusens, P
Sileghem, A
Volders, P
Van Den Bosch, F
Verschueren, P
Westhovens, R
This article is maintained by: Elsevier
Article Title: Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
Journal Title: Annals of the Rheumatic Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1136/annrheumdis-2014-205489
Content Type: article
Copyright: Copyright © 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.